Aspen invests in Port Elizabeth

South Africa’s Aspen will invest an additional ZAR3.4 billion (US$238 million) at its domestic Port Elizabeth manufacturing site, in “South Africa’s single biggest pharmaceutical investment”.

South Africa’s Aspen will invest an additional ZAR3.4 billion (US$238 million) at its domestic Port Elizabeth manufacturing site, in “South Africa’s single biggest pharmaceutical investment”.

Citing South African President Cyril Ramaphosa’s “commitment to establishing a more predictable, stable investment environment and reducing regulatory burden” as...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Manufacturing

More from Business